Literature DB >> 22260521

Upper normal threshold of serum alanine aminotransferase in identifying individuals at risk for chronic liver disease.

Ha Na Park1, Dong Hyun Sinn, Geum-Youn Gwak, Jee Eun Kim, Sang Youl Rhee, Sung June Eo, Yu Jin Kim, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Byung Chul Yoo.   

Abstract

BACKGROUND/AIMS: Serum alanine aminotransferase (ALT) is an easily available, low-cost screening tool for detecting silent chronic liver disease. Recent studies have suggested that the currently accepted healthy ALT thresholds be lowered.
METHODS: In this retrospective cross-sectional study, we determined upper thresholds for ALT values in a nationally representative healthy cohort (n = 3337) from the Fourth Korea National Health and Nutrition Examination Survey (KNHANES IV). Sensitivity and specificity of the currently used ALT threshold (40 IU/L, regardless of gender) was compared against study-derived, gender-specific ALT thresholds for detecting individuals at risk for chronic liver disease in 27 913 health check-up participants.
RESULTS: The 95th percentile levels for ALT in healthy weight, metabolically normal, liver disease-free KNHANES participants were 34 IU/L for men and 25 IU/L for women. The prevalence of ALT elevation among health check-up participants was 11.0% in currently used thresholds, and increased to 22.6% with study-derived, gender-specific thresholds. Of the population who were additionally defined to have elevated ALT levels under new ALT threshold, 65.7% were at risk for chronic liver disease. Sensitivity for detecting individuals at risk for chronic liver disease improved from 18 to 33% with new thresholds whereas a trade-off in specificity (from 96 to 88%) was observed.
CONCLUSIONS: It is recommendable to lower the current ALT thresholds to better identify individuals at risk for chronic liver disease.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22260521     DOI: 10.1111/j.1478-3231.2011.02749.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  16 in total

1.  Trihalomethane exposure and biomonitoring for the liver injury indicator, alanine aminotransferase, in the United States population (NHANES 1999-2006).

Authors:  James B Burch; Todd M Everson; Ratanesh K Seth; Michael D Wirth; Saurabh Chatterjee
Journal:  Sci Total Environ       Date:  2015-04-02       Impact factor: 7.963

2.  Factors associated with significant liver fibrosis assessed using transient elastography in general population.

Authors:  Seng Chan You; Kwang Joon Kim; Seung Up Kim; Beom Kyung Kim; Jun Yong Park; Do Young Kim; Sang Hoon Ahn; Won Jae Lee; Kwang-Hyub Han
Journal:  World J Gastroenterol       Date:  2015-01-28       Impact factor: 5.742

Review 3.  KASL clinical practice guidelines for management of chronic hepatitis B.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2019-06-12

4.  Estimation of Upper Limit of Normal for Serum Alanine Transaminase in Healthy South Indian Population.

Authors:  Pazhanivel Mohan; Varun Sundar; Emmanuel Bhaskar; Syluvai Anthony
Journal:  Indian J Clin Biochem       Date:  2016-09-17

5.  KASL clinical practice guidelines for management of chronic hepatitis B.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2022-04-01

6.  Disease progression in chronic hepatitis C patients with normal alanine aminotransferase levels.

Authors:  Dong Hyun Sinn; Geum-Youn Gwak; Jae-Uk Shin; Moon Seok Choi; Joon Hyeok Lee; Kwang Cheol Koh; Seung Woon Paik; Byung Chul Yoo
Journal:  World J Gastroenterol       Date:  2013       Impact factor: 5.742

7.  Waist-to-height ratio is more closely associated with alanine aminotransferase levels than body mass index and waist circumference among population-based children: a cross-sectional study in Japan.

Authors:  Hirotaka Ochiai; Takako Shirasawa; Rimei Nishimura; Hinako Nanri; Tadahiro Ohtsu; Hiromi Hoshino; Naoko Tajima; Akatsuki Kokaze
Journal:  BMC Pediatr       Date:  2015-05-17       Impact factor: 2.125

Review 8.  Non-Alcoholic Steatohepatitis: Limited Available Treatment Options but Promising Drugs in Development and Recent Progress Towards a Regulatory Approval Pathway.

Authors:  Claudia Filozof; Barry J Goldstein; Richard N Williams; Arun Sanyal
Journal:  Drugs       Date:  2015-08       Impact factor: 9.546

9.  Factors associated with prognostic or treatment outcomes in HIV/AIDS patients with and without hypertension in Eswatini.

Authors:  Sabelo Bonginkosi Dlamini; Hans-Uwe Dahms; Ming-Tsang Wu
Journal:  Sci Rep       Date:  2021-06-21       Impact factor: 4.379

10.  Normal liver enzymes are correlated with severity of metabolic syndrome in a large population based cohort.

Authors:  Julia Kälsch; Lars P Bechmann; Dominik Heider; Jan Best; Paul Manka; Hagen Kälsch; Jan-Peter Sowa; Susanne Moebus; Uta Slomiany; Karl-Heinz Jöckel; Raimund Erbel; Guido Gerken; Ali Canbay
Journal:  Sci Rep       Date:  2015-08-13       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.